Carrie Nagorka, Senior Editor

A session at Maui Derm Hawaii 2023 explored new therapies and devices that will impact the future of aesthetic and medical dermatology.

At Maui Derm Hawaii 2023, David Laub, MD, shares pearls from his sessions on achieving the optimal cosmetic outcome.

Elena Hawryluk, MD, PhD, associate professor of dermatology at Harvard Medical School, shares highlights from her Maui Derm Hawaii 2023 sessions.

Raj Chovatiya, MD, PhD, talks about difficult cases and exciting new treatment options at Maui Derm Hawaii 2023.

At the Maui Derm Hawaii 2023 conference, Ilona Frieden, MD, has the honor of presenting the Alan Shalita Memorial Lecture. She talked to Dermatology Times® about her presentation, "Nevus Flammeus, Port-wine stains, Capillary malformations and beyond: A 30+ year journey". During this lecture, Frieden reviews her experiences treating port-wine birthmarks, as well as understanding causes, disease associations, and future treatments.

Linda Stein Gold, MD, clears up confusion regarding various treatment options for patients with mild to moderate forms of the disease.

Suzanne Kilmer, MD, discusses some of the exciting laser therapies she is showcasing at the 2023 Maui Derm Hawaii Conference.

Ilona Frieden, MD, highlights her session at Maui Derm Hawaii on new therapies for treating pediatric cases in dermatology.

Maui Derm is underway in Maui, Hawaii, offering a multitude of presentations and workshops for the dermatology community.

Experts at Maui Derm Hawaii offer the latest findings and research in treating acne vulgaris in adolescents.

Maui Derm founder, George Martin, MD, gives a preview of the 2023 Maui Derm Hawaii Dermatology Conference at the Grand Wailea Resort on Maui.

Suzanne Kilmer, MD, Founder of the Laser & Skin Surgery Center of Northern California, and clinical professor at the University of California talks about why she is excited for Maui Derm Hawaii 2023.

Neal Bhatia, MD, gives insight into his shared sessions at the 2023 Maui Derm Hawaii conference.

Aloha! The 2023 Maui Derm Hawaii Dermatology Conference begins today at the Grand Wailea Resort on Maui.

Renata Block, MMS, PA-C, and member of the Dermatology Times Editorial Board, talks about the Society of Dermatology Physician Assistants (SDPA) and exciting times ahead in the field.

Recommendations were made for patients to help relieve inflammation, itching and infections.

Union therapeutics is also developing the drug for treatment of atopic dermatitis and hidradenitis suppurativa.

VP-102 could be the first approved drug on the market in the US to treat molluscum contagiosum.

Dermatology Times®’ Editorial Board offers insight on what they loved about 2022, and what they hope to see in 2023.

The 16-week study by Leo Pharma assessed the efficacy of the cream in adults.

Patient enrollment is now open for the study conducted by late-stage biopharmaceutical company, Soligenix.

The PharmaJet Stratis Needle-free Injection System’s vaccine could help prevent a rare but aggressive form of skin cancer.

At the RAD 2022 Conference, Keri Kelley, Senior Outreach and Community Manager at Global Parents for Eczema Research discussed a program aimed at providing support for eczema caregivers.

At the 2022 RAD virtual conference, a dermatologist examines treatment options for AD in various racial and ethnic groups.

A 2022 RAD Conference poster presentation explores the efficacy of the therapy for the treatment or prevention of AD.

Mona Shahriari, MD, Assistant Clinical Professor of Dermatology at Yale University School of Medicine, shares what she is looking forward to at the Revolutionizing Atopic Dermatitis virtual conference.

This is the first phase 3 evidence to suggest the drug as a promising treatment approach in adult patients.

New research suggests new pharmacological therapies are associated with a decrease in melanoma-related deaths.

Patricia Farris, MD, shares some of the highlights that will be presented at the 2023 South Beach Symposium in Miami Beach, Florida.

New Clinical Trial Evidence Does Not Support Dairy Avoidance as a Beneficial Treatment for Pediatric AD.